A team from Precisa Medicamentos visited the Bharat Biotech facility last week to discuss potential export possibilities of the vaccine, the company said in a release.
Bharat Biotech says it has followed necessary protocol and preliminary review shows death unrelated to study. Volunteer sample being tested to determine cause of death.
The lack of regulatory clarity coupled with lack of transparency from CDSCO raises questions on the safety and efficacy of the Covid-19 vaccine candidates.
As India gears up to roll out a national vaccination programme, Bharat Biotech and Serum Institute's barbs at each other will only add to vaccine hesitancy.
Officials say India 'will not be in a rush', and Bangladesh, Bhutan, Nepal, Sri Lanka will get ‘priority’ after domestic demand for the Covid vaccines is fulfilled.
The joint statement comes after Bharat Biotech MD Dr Krishna Ella hit out at Serum CEO Adar Poonawalla’s comment that only Pfizer, Moderna, Oxford vaccines were effective.
In episode 653 of ‘Cut The Clutter’, the first in the new year, ThePrint’s Editor-in-Chief Shekhar Gupta explained working of Covaxin, Covishield & Zydus Cadila’s DNA vaccine.
The Modi govt must not damage India’s competitive advantage in vaccines & pharmaceuticals through absurd benchmarks that will not be trusted by other countries.
Bharat Biotech MD Dr Krishna Ella says they gave ‘excellent safety data tested on around 25,000 participants’ & their efficacy data will be available by February-March.
The claim that VB-GRAMG provides an employment guarantee is incorrect. The only guarantee is to 'empower' the Centre to allow partial implementation in notified areas alone.
It is argued that India-Israel ties are moving from buyer–seller dynamic to one focused on joint development & manufacturing partnership, a shift 'more durable' than traditional arms sales.
If Pathaan gave both conservatives and liberals room to hide, Dhurandhar extends no such courtesy. Aditya Dhar ripped open that tent of hypocrisy and turned the knife.
COMMENTS